PROCEPT BioRobotics Corporation (PRCT) Misses Q4 EPS by 10c

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q4 EPS of ($0.54), $0.10 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $43.6 million versus the consensus estimate of $41.49 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating